AUY922 Completed Phase 2 Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01922583AUY922 in Patient With Stage IV NSCLC
NCT01854034Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR
NCT01124864A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.